Campbell’s (NASDAQ:CPB) Price Target Lowered to $24.00 at UBS Group

Campbell’s (NASDAQ:CPB) had its target price lowered by stock analysts at UBS Group from $26.00 to $24.00 in a research report issued on Friday,Benzinga reports. The firm presently has a “sell” rating on the stock. UBS Group’s price objective indicates a potential downside of 6.14% from the company’s current price.

A number of other brokerages also recently weighed in on CPB. Stephens cut their target price on Campbell’s from $40.00 to $38.00 and set an “overweight” rating on the stock in a research note on Monday, December 8th. Morgan Stanley cut their price objective on Campbell’s from $28.00 to $27.00 and set an “equal weight” rating on the stock in a research report on Friday. Barclays set a $27.00 price objective on Campbell’s in a research note on Friday, January 16th. Royal Bank Of Canada lowered their target price on Campbell’s from $35.00 to $30.00 and set a “sector perform” rating on the stock in a research note on Wednesday, December 10th. Finally, DA Davidson restated a “neutral” rating and set a $30.00 price target on shares of Campbell’s in a research report on Thursday, December 11th. Two investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and five have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average target price of $31.35.

Campbell’s Stock Up 2.0%

NASDAQ:CPB traded up $0.51 during trading hours on Friday, hitting $25.57. 5,234,323 shares of the company traded hands, compared to its average volume of 7,313,286. The company has a quick ratio of 0.34, a current ratio of 0.82 and a debt-to-equity ratio of 1.54. The company has a market cap of $7.62 billion, a PE ratio of 13.25, a PEG ratio of 8.82 and a beta of -0.03. The firm’s 50-day simple moving average is $27.27 and its 200-day simple moving average is $29.75. Campbell’s has a one year low of $24.86 and a one year high of $43.85.

Campbell’s (NASDAQ:CPB) last announced its earnings results on Tuesday, December 9th. The company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.73 by $0.04. Campbell’s had a net margin of 5.69% and a return on equity of 21.84%. The company had revenue of $2.68 billion during the quarter. The company’s quarterly revenue was down 3.4% compared to the same quarter last year. Campbell’s has set its FY 2026 guidance at 2.400-2.550 EPS. Equities analysts predict that Campbell’s will post 3.15 earnings per share for the current year.

Insider Activity at Campbell’s

In related news, EVP Charles A. Brawley III sold 11,550 shares of the stock in a transaction dated Tuesday, December 30th. The stock was sold at an average price of $28.14, for a total transaction of $325,017.00. Following the sale, the executive vice president owned 43,777 shares of the company’s stock, valued at approximately $1,231,884.78. This represents a 20.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Anthony Sanzio sold 2,700 shares of Campbell’s stock in a transaction dated Friday, January 9th. The shares were sold at an average price of $26.51, for a total value of $71,577.00. Following the transaction, the executive vice president directly owned 25,264 shares of the company’s stock, valued at $669,748.64. The trade was a 9.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 19.78% of the stock is currently owned by company insiders.

Institutional Trading of Campbell’s

Several institutional investors and hedge funds have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Campbell’s by 3.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,472 shares of the company’s stock worth $777,000 after buying an additional 685 shares during the last quarter. Goldman Sachs Group Inc. raised its position in Campbell’s by 4.3% during the first quarter. Goldman Sachs Group Inc. now owns 660,543 shares of the company’s stock valued at $26,369,000 after purchasing an additional 27,374 shares in the last quarter. Empowered Funds LLC bought a new stake in Campbell’s during the first quarter worth about $446,000. Woodline Partners LP boosted its holdings in shares of Campbell’s by 40.9% in the 1st quarter. Woodline Partners LP now owns 16,623 shares of the company’s stock worth $664,000 after purchasing an additional 4,827 shares in the last quarter. Finally, Geneos Wealth Management Inc. boosted its holdings in shares of Campbell’s by 333.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 975 shares of the company’s stock worth $39,000 after purchasing an additional 750 shares in the last quarter. 52.35% of the stock is currently owned by hedge funds and other institutional investors.

About Campbell’s

Campbell’s (NASDAQ: CPB) is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell’s has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.

The company’s brand portfolio includes Campbell’s Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.